Literature DB >> 19353623

Adenovirus gene therapy for pediatric cancers: shall we gather at the liver?

James I Geller1, Timothy P Cripe.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19353623      PMCID： PMC2858055          DOI： 10.1002/pbc.22033

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  32 in total

1.  A death in the laboratory: the politics of the Gelsinger aftermath.

Authors:  I H Carmen
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

2.  Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.

Authors:  Mary K Danks; K Jin Yoon; Rebecca A Bush; Joanna S Remack; Monika Wierdl; Lyudmila Tsurkan; Seung U Kim; Elizabeth Garcia; Marianne Z Metz; Joseph Najbauer; Philip M Potter; Karen S Aboody
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.

Authors:  F Sasaki; T Matsunaga; M Iwafuchi; Y Hayashi; H Ohkawa; M Ohira; T Okamatsu; T Sugito; Y Tsuchida; A Toyosaka; N Nagahara; H Nishihira; Y Hata; J Uchino; K Misugi; N Ohnuma
Journal:  J Pediatr Surg       Date:  2002-06       Impact factor: 2.545

4.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors:  M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

5.  Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.

Authors:  J A Ortega; E C Douglass; J H Feusner; M Reynolds; J J Quinn; M J Finegold; J E Haas; D R King; W Liu-Mares; M G Sensel; M D Krailo
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity.

Authors:  J Nemunaitis; C Cunningham; A Buchanan; A Blackburn; G Edelman; P Maples; G Netto; A Tong; B Randlev; S Olson; D Kirn
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

Review 7.  History of oncolytic viruses: genesis to genetic engineering.

Authors:  Elizabeth Kelly; Stephen J Russell
Journal:  Mol Ther       Date:  2007-02-13       Impact factor: 11.454

8.  Hepatoblastoma and low birth weight: a trend or chance observation?

Authors:  James Feusner; J Plaschkes
Journal:  Med Pediatr Oncol       Date:  2002-11

9.  [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].

Authors:  B Häberle; U Bode; D von Schweinitz
Journal:  Klin Padiatr       Date:  2003 May-Jun       Impact factor: 1.349

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.